GO
Loading...

Merck & Co Inc

More

  • July 24- Bristol-Myers Squibb Co reported better-than-expected quarterly results, helped by cost controls and strong sales of its Eliquis blood clot preventer and Yervoy treatment for melanoma. Sales of Eliquis, which Bristol-Myers co-markets with Pfizer Inc, rose to $171 million.

  • LONDON/ MUMBAI, July 22- Indian generics firm Lupin, some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by GlaxoSmithKline, five sources familiar with the matter said.

  • Studies see new risks for cholesterol drug niacin Wednesday, 16 Jul 2014 | 5:10 PM ET

    New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use. Those details are in this week's New England Journal of Medicine.

  • S.Korea delays lifting ban on beef with feed additive Tuesday, 15 Jul 2014 | 11:04 PM ET

    SEOUL, July 16- South Korea has delayed a move to allow certain levels of the animal feed additive zilpaterol in beef to August from mid-July as it finalizes the policy, a food ministry official said on Wednesday.

  • FACTBOX-M&A frenzy transforming global pharma Monday, 14 Jul 2014 | 9:27 AM ET

    July 14- Several multi-billion dollar deals and bids have made 2014 a busy year for healthcare acquisitions, despite Pfizer pulling its $118 billion offer for AstraZeneca.

  • July 11- Big Pharma companies are trying to offload low-growth, mature drug portfolios to firms such as Blackstone Group LP and TPG Capital LP which need to figure out how to carve them out, in one of private equity's greatest dealmaking challenges.

  • July 11- Two members of the U.S. Senate Finance Committee, including Chairman Ron Wyden, on Friday asked Gilead Sciences Inc to defend the more than $80,000 cost of its breakthrough treatment for hepatitis C, citing the expense to federal healthcare programs.

  • BRUSSELS July 8- Omega Pharma NV, a Belgian healthcare products distributor, said any speculation about the future of the company was premature as no decision had yet been taken, following a report that it could sell itself.

  • Start-up gives dogs’ tags an upgrade Wednesday, 2 Jul 2014 | 10:37 AM ET
    Golden Retriever wearing a Tagg device.

    Tagg CEO explained his big idea --tracking beloved pets at all times via smartphone -- to the Power Pitch panel.

  • FRANKFURT, July 1- German drugmaker Bayer said it would keep the Dr. Scholl's and Coppertone- each worth more than $1 billion- Bayer said it was not planning to untie the Merck bundle it secured in May in a competitive bidding tussle with Reckitt Benckiser, Procter& Gamble Co and Novartis.

  • FRANKFURT, July 1- German drugmaker Bayer said it would keep the Dr. Scholl's and Coppertone- each worth more than $1 billion- Bayer said it was not planning to untie the Merck bundle it secured in May in a competitive bidding tussle with Reckitt Benckiser, Procter& Gamble Co and Novartis.

  • Midday movers: Allergan, MBIA, Treehouse Foods & More Monday, 30 Jun 2014 | 12:13 PM ET
    NYSE EuroNext flag hangs outside the NYSE.

    Some of Monday's midday movers:

  • Stocks end mildly up; second weekly gain for Nasdaq Friday, 27 Jun 2014 | 4:27 PM ET
    Trader on the floor of the New York Stock Exchange.

    Stocks fell on Friday after a report on consumer confidence.

  • Investor conundrum: Play cyclical or secular? Thursday, 26 Jun 2014 | 6:00 PM ET

    Before you put your next dollar in stocks, Cramer would like a word about cyclical versus secular stocks.

  • US STOCKS-Wall St gains with drugmakers, broadcasters Wednesday, 25 Jun 2014 | 5:09 PM ET

    *Monsanto rallies on outlook and stock-repurchase plans. *CBS shares jump after Supreme Court ruling. Shares of CBS jumped 6.2 percent to $62.48 after the U.S. Supreme Court ruled that online TV startup Aereo Inc violates copyright law by using tiny antennas to provide subscribers with broadcast network content via the Internet.

  • US stocks finish higher; S&P 500 near record close Wednesday, 25 Jun 2014 | 4:51 PM ET
    Trader on the floor of the New York Stock Exchange.

    U.S. stocks rose on Wednesday after mixed economic reports.

  • June 24- A late-stage trial testing Bristol-Myers Squibb Co's cancer immunotherapy nivolumab in advanced melanoma patients was halted early after it was determined that the drug was likely to prolong survival, the company said on Tuesday.

  • Aging stinks, so at least make some money from it Monday, 23 Jun 2014 | 8:00 AM ET

    The US population is getting grayer, and while getting old stinks, there are plenty of ways to profit from an aging demographic using ETFs.

  • NEW YORK, June 20- In the race to find a faster cure for hepatitis C, Bristol-Myers Squibb Co said it will test its experimental antiviral drug combination with Gilead Sciences Inc's blockbuster drug Sovaldi, hoping to cut treatment time to four weeks.

  • Midday movers: Nokia, Walgreen, Yelp & More Wednesday, 18 Jun 2014 | 1:00 PM ET
    Traders on the floor of the New York Stock Exchange.

    Some of Wednesday's midday movers: